Browsing by Author Готько, Євген Степанович

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 45  next >
Issue DateTitleAuthor(s)
2013A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the PAVES StudyГотько, Євген Степанович; Tamás Pintera; Zandra Klippel; Alvydas Cesas; Adina Croitoru; Jochen Decaestecker; Peter Gibbs; Jacek Jassem; Galina Kurteva; Jan Novotny; Seamus O’Reilly; Tomas Salek; Maureen Reiner
2015Analysis of KRAS/NRAS Mutations in a Phase 3 Study of Panitumumab With FOLFIRI Compared With FOLFIRI Alone as Second-Line Treatment for Metastatic Colorectal CancerГотько, Євген Степанович; Marc Peeters; Kelly S. Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis J. A. Punt; Andrew Strickland
2001-02Brest cancer in men. A raview of 79 patients who presented to the Transcarathian Regional Oncological Clinical Dispensary during 53 years: 1946-1999Готько, Євген Степанович; Щадей, Олександр
2014-02Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation statusГотько, Євген Степанович; Shikha Gaur; Linling Chen; Vincent Ann; Wei-Chen Lin; Yafan Wang; Vincent HS Chang; Her-Shuyong Shia; Nan Yong Hsu; Yun Yen
2009-03Etude de phase III (20050181) de l’association panitumumab + 5-fluorouracile, acide folinique, irinotecan (Folfiri) versus Folfiri seul en seconde ligne de traitement des cancers colorectaux métastasés. Analyse poolée de toxicitéГотько, Євген Степанович; M. Ducreux; G. Wilson; A. Cervantès; T. André; F. Lordick; S. Collins; M. Shing; T. Price; M. Peeters
2014Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancerГотько, Євген Степанович; T. J. Price; A. Cervantès; A. F. Sobrero; M. Ducreux; T. André; E. Chan; F. Lordick; C. J. A. Punt; A. H. Strickland; G. Wilson; T. E. Ciuleanu; L. Roman; E. Van Cutsem; Y. Tian R. Sidhu; M. Peeters
2015Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)Готько, Євген Степанович; T. Pinter P.K. Morrow A. Cesas A. Croitoru J. Decaestecker P. Gibbs; J. Jassem G. Kurteva J. Novotny S. O'Reilly T. Salek L. Khosrowshahi M. Reiner Z. Klippel C. Blanke
2012Final results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)Готько, Євген Степанович; Alberto F. Sobrero; Marc Peeters; Timothy Jay Price; Andres Cervantes-Ruiperez; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Ying Tian; Roger Sidhu
2014HORMONOTHERAPY IN PATIENTS WITH BILATERAL BREAST CANCERГотько, Євген Степанович; D.Y. Tsyhyka; S.V. Zhero; D.V. Prygara; N.Y. Pogorelova; O.I. Tsyhyka; V.Y. Ihnatko; O.T. Devinyak
2016-10-20Maintenance erlotinib versus erlotinib at disease progression inpatients with advanced non-small-cell lung cancer who have notprogressed following platinum-based chemotherapy (IUNO study)Готько, Євген Степанович; Saulius Cicènas; Sarayut Lucien; Geater Petar Petrov; Gregory Hooper; Fan Xia; Nadejda Mudie; Yi-Long Wu
2013MALE BREAST CANCER: CLINICAL PRESENTATION, DIAGNOSIS, TREATMENГотько, Євген Степанович
2000-05PAK Молочной железы у мужчинГотько, Євген Степанович
2016Peculiarities of breast cancer incidence rate in urban population and implementation of screening programs in health care systemГотько, Євген Степанович; Svyatoslav V Zhero; Dmytro Y Tsyhyka; Victor Y Ihnatko; Natalia Y Pohorelova
2010-11-01Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal CancerГотько, Євген Степанович; Peeters, Marc; Jay Price, Timothy
2008-07Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-NaЇve Advanced Non-small Cell Lung CancerГотько, Євген Степанович; Mary, E. R.
2013-12Receptor status of tumor as prognostic factor in patients with bilateral breast cancerЦигика, Дмитро Йосипович; Готько, Євген Степанович; Девіняк, Олег Теодозійович
2013Resultsof a phase III, randomized, double-blind, placebocontrolledtrialofpegfilgrastim (PEG) inpatients (pts) receivingfirst-line FOLFOX or FOLFIRI andbevacizumab (B) forcolorectalcancer (CRC)Готько, Євген Степанович; Tamas Pinter; Esteban Abella; Alvydas Cesas; Adina Croitoru; Jochen Decaestecker; Peter Gibbs; Jacek Jassem; Galina Petrova Kurteva; Jan Novotny; Seamus O'Reilly; Tomas Salek; May F. Mo
2014-05-20Updated analysis of KRAS/NRAS and BRAF mutations in study 20050181 of panitumumab (pmab) plus FOLFIRI for second-line treatment (tx) of metastatic colorectal cancer (mCRC).Готько, Євген Степанович; Marc Peeters; Kelly Smith Oliner; Timothy Jay Price; Andres Cervantes; Alberto F. Sobrero; Michel Ducreux; Thierry Andre; Emily Chan; Florian Lordick; Cornelis JA Punt; Andrew Strickland; Gregory Wilson
2014Білатеральний рак молочних залоз: фактори ризику, прогнозу та моніторинг пацієнтівГотько, Євген Степанович; Цигика, Дмитро Йосипович; Рогач, Іван Михайлович; Жеро, Святослав Владиславович; Погорєлова, Наталія Євгенівна; Пригара, Дмитро Васильович; Готько, Ірина Юріївна; Ігнатко, Віктор Ярославович
2013Вид хірургічного лікування як прогностичний чинник білатерального раку молочної залозиГотько, Євген Степанович; Цигика, Дмитро Йосипович; Девіняк, Олег Теодозійович